Remote monitoring of patients with NYHA functional class II-III chronic heart failure using the M-Cardio mobile application in residents of Kyrgyzstan.
A R Rustambekova, A I Moldomamatova, K A Askarbekova, M A Abbasova, A M Noruzbaeva
{"title":"Remote monitoring of patients with NYHA functional class II-III chronic heart failure using the M-Cardio mobile application in residents of Kyrgyzstan.","authors":"A R Rustambekova, A I Moldomamatova, K A Askarbekova, M A Abbasova, A M Noruzbaeva","doi":"10.18087/cardio.2025.6.n2928","DOIUrl":null,"url":null,"abstract":"<p><p>Aim Development and implementation of the M-Cardio mobile application for remote monitoring of patients with chronic heart failure (CHF) at the outpatient stage with an assessment of clinical effectiveness.Material and methods This study included 244 patients with NYHA functional class (FC) II-III CHF of ischemic etiology. During the inpatient phase, the patients were taught the basics of self-monitoring and self-care in CHF. In addition, patients of the main group were trained in using the M-Cardio mobile application. Patients were randomized into 2 groups: Group 1 was the main group, with further remote monitoring using the mobile application (n = 127), Group 2 was a control group, with standard outpatient monitoring at the patient's residence (n = 117). The original version of the mobile application was downloaded to the smartphones of the participants in the main group. The app contained a developed algorithm of clinical indicators, which allows real-time assessment of the patient's condition based on the quantitative deviations above or below threshold values. This algorithm includes 7 items, shortness of breath, position in bed, palpitation, edema, body weight, blood pressure (BP), and heart rate (HR), which the patient fills in twice a week or every day if necessary. A possibility is also included for automated information of the doctor and the patient to specify recommendations and timely adjust the treatment. The follow-up period was 12 months. Results 244 patients with NYHA FC II-III CHF of ischemic etiology were selected and enrolled in the study, including 155 (63.5%) men and 89 (36.5%) women (mean age, 61±7.4 years). NYHA FC II CHF was detected in 50 (20.4%) patients and NYHA FC III CHF in 194 (75.5%) patients. The mean left ventricular ejection fraction was 41.6±10.7%.Conclusion Preliminary results of the study indicated that the use of remote monitoring of CHF patients was significantly associated with an improvement in their quality of life, ability for self-care, and the functional status. The effectiveness of the M-Cardio mobile application in the remote monitoring of outpatients is based on a decreased frequency of rehospitalizations and an increased survival.</p>","PeriodicalId":54750,"journal":{"name":"Kardiologiya","volume":"65 6","pages":"44-53"},"PeriodicalIF":0.5000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kardiologiya","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18087/cardio.2025.6.n2928","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Aim Development and implementation of the M-Cardio mobile application for remote monitoring of patients with chronic heart failure (CHF) at the outpatient stage with an assessment of clinical effectiveness.Material and methods This study included 244 patients with NYHA functional class (FC) II-III CHF of ischemic etiology. During the inpatient phase, the patients were taught the basics of self-monitoring and self-care in CHF. In addition, patients of the main group were trained in using the M-Cardio mobile application. Patients were randomized into 2 groups: Group 1 was the main group, with further remote monitoring using the mobile application (n = 127), Group 2 was a control group, with standard outpatient monitoring at the patient's residence (n = 117). The original version of the mobile application was downloaded to the smartphones of the participants in the main group. The app contained a developed algorithm of clinical indicators, which allows real-time assessment of the patient's condition based on the quantitative deviations above or below threshold values. This algorithm includes 7 items, shortness of breath, position in bed, palpitation, edema, body weight, blood pressure (BP), and heart rate (HR), which the patient fills in twice a week or every day if necessary. A possibility is also included for automated information of the doctor and the patient to specify recommendations and timely adjust the treatment. The follow-up period was 12 months. Results 244 patients with NYHA FC II-III CHF of ischemic etiology were selected and enrolled in the study, including 155 (63.5%) men and 89 (36.5%) women (mean age, 61±7.4 years). NYHA FC II CHF was detected in 50 (20.4%) patients and NYHA FC III CHF in 194 (75.5%) patients. The mean left ventricular ejection fraction was 41.6±10.7%.Conclusion Preliminary results of the study indicated that the use of remote monitoring of CHF patients was significantly associated with an improvement in their quality of life, ability for self-care, and the functional status. The effectiveness of the M-Cardio mobile application in the remote monitoring of outpatients is based on a decreased frequency of rehospitalizations and an increased survival.
目的开发和实施M-Cardio移动应用程序,用于在门诊阶段对慢性心力衰竭(CHF)患者进行远程监测并评估临床效果。材料与方法本研究纳入244例缺血性病因NYHA功能分级(FC) II-III型CHF患者。在住院期间,患者被教导在CHF中自我监测和自我护理的基础知识。此外,对主组患者进行M-Cardio移动应用程序的使用培训。将患者随机分为两组:第一组为主要组,使用移动应用程序进行进一步远程监测(n = 127);第二组为对照组,在患者住所进行标准门诊监测(n = 117)。手机应用程序的原始版本被下载到主组参与者的智能手机上。该应用程序包含一种开发的临床指标算法,可以根据高于或低于阈值的定量偏差实时评估患者的病情。该算法包括呼吸短促、床位、心悸、水肿、体重、血压(BP)、心率(HR) 7个项目,患者每周填写两次,必要时每天填写。还可能包括医生和患者的自动信息,以指定建议和及时调整治疗。随访期为12个月。结果244例缺血性NYHA FC II-III型CHF患者入选研究,其中男性155例(63.5%),女性89例(36.5%),平均年龄61±7.4岁。50例(20.4%)患者检出NYHA FC II型CHF, 194例(75.5%)患者检出NYHA FC III型CHF。平均左室射血分数为41.6±10.7%。结论本研究初步结果表明,使用远程监护与CHF患者生活质量、生活自理能力和功能状态的改善显著相关。M-Cardio移动应用程序在门诊患者远程监测中的有效性是基于再住院频率的降低和生存率的提高。
期刊介绍:
“Kardiologiya” (Cardiology) is a monthly scientific, peer-reviewed journal committed to both basic cardiovascular medicine and practical aspects of cardiology.
As the leader in its field, “Kardiologiya” provides original coverage of recent progress in cardiovascular medicine. We publish state-of-the-art articles integrating clinical and research activities in the fields of basic cardiovascular science and clinical cardiology, with a focus on emerging issues in cardiovascular disease. Our target audience spans a diversity of health care professionals and medical researchers working in cardiovascular medicine and related fields.
The principal language of the Journal is Russian, an additional language – English (title, authors’ information, abstract, keywords).
“Kardiologiya” is a peer-reviewed scientific journal. All articles are reviewed by scientists, who gained high international prestige in cardiovascular science and clinical cardiology. The Journal is currently cited and indexed in major Abstracting & Indexing databases: Web of Science, Medline and Scopus.
The Journal''s primary objectives
Contribute to raising the professional level of medical researchers, physicians and academic teachers.
Present the results of current research and clinical observations, explore the effectiveness of drug and non-drug treatments of heart disease, inform about new diagnostic techniques; discuss current trends and new advancements in clinical cardiology, contribute to continuing medical education, inform readers about results of Russian and international scientific forums;
Further improve the general quality of reviewing and editing of manuscripts submitted for publication;
Provide the widest possible dissemination of the published articles, among the global scientific community;
Extend distribution and indexing of scientific publications in major Abstracting & Indexing databases.